{"id":699,"date":"2018-07-25T16:56:44","date_gmt":"2018-07-25T16:56:44","guid":{"rendered":"https:\/\/wp.uthscsa.edu\/nephrology\/?page_id=699"},"modified":"2025-09-10T16:23:15","modified_gmt":"2025-09-10T21:23:15","slug":"clinical-trials","status":"publish","type":"page","link":"https:\/\/lsom.uthscsa.edu\/nephrology\/patient-care\/clinical-trials\/","title":{"rendered":"Clinical Trials"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row][vc_column width=&#8221;2\/3&#8243;][vc_column_text]Clinical trials are part of clinical research and are at the heart of all medical discoveries. Your voluntary participation in a clinical trial may lead to new and better treatment for kidney disease in near future.<\/p>\n<p>Nephrologists (kidney doctors) at UT Health San Antonio conduct clinical research trials. To learn more about how you can participate in one of the following clinical research trials, please call at 210-358-7447:[\/vc_column_text][vc_column_text css=&#8221;&#8221;]<\/p>\n<h2><strong>Active clinical trials at The Center for Precision Medicine and UT Nephrology:<\/strong><\/h2>\n<h3 class=\"colorized-heading\">ARTEMIS: Ravulizumab to Protect Patients With CKD From CSA-AKI and MAKE (ARTEMIS) (Sponsor: Alexion Pharmaceuticals, Inc)<\/h3>\n<p>The primary objective of this study is to assess the efficacy of ravulizumab compared with placebo in reducing the risk of the clinical consequences of acute kidney injury at 90 days in adult participants with CKD who undergo non-emergent cardiac surgery with cardiopulmonary bypass.<\/p>\n<ul>\n<li>Known CKD for at least 90 days (CKD Stage 3A, 3B, or 4) with planned non-emergent sternotomy with CPB procedure.<\/li>\n<li>18 Years to 90 Years<\/li>\n<li>Location: University Hospital<\/li>\n<\/ul>\n<p>Principal Investigator: Ghassan Bandak, MD <a href=\"mailto:bandak@uthscsa.edu\">bandak@uthscsa.edu<\/a><br \/>\nContact: 210 450 7305, Clinical Trials, Department of Medicine, UT Health<br \/>\n<a class=\"carat-double\" href=\"https:\/\/clinicaltrials.gov\/study\/NCT05746559\">Enroll in trial<\/a><\/p>\n<hr>\n<h3 class=\"colorized-heading\">STUDY00000897: EMPA on urine adenine-creatinine ratio. (Sponsor: Investigator Initiated)<\/h3>\n<p>This study evaluates the effects of SGLT2i, or Sodium-Glucose Cotransporter-2 inhibitors in reducing endogenous adenine in patients with CKD admitted to hospital with heart failure.<\/p>\n<ul>\n<li>Known CKD (Stage 3A, 3B, or 4) and admission to hospital with heart failure<\/li>\n<li>18 Years to 75 Years<\/li>\n<li>Location: University Hospital<\/li>\n<\/ul>\n<p>Principal Investigator: Allen S. Anderson, MD<br \/>\nContact: 210 450 8333, <a href=\"mailto:nath@uthscsa.edu\">nath@uthscsa.edu <\/a><\/p>\n<hr>\n<h3 class=\"colorized-heading\">20210436HU: Metabolomic study in renal biopsy specimens (Sponsor: Investigator Initiated)<\/h3>\n<p>To establish a tissue interrogation site to employ untargeted and targeted spatial metabolomics and other basic analysis of tissues from renal biopsy to assess cellular metabolic states associated with healthy function, activation of disease, acute injury, chronic condition, and recovery.<\/p>\n<ul>\n<li>Age: adults more than 18 years of age<\/li>\n<li>Diagnosis: kidney pathology requiring biopsy<\/li>\n<li>Location: UT clinics and University Hospital<\/li>\n<\/ul>\n<p>Principal Investigator: Swetha R. Kanduri, MD<br \/>\nContact: 210 450 8333, <a href=\"kanduri@uthscsa.edu\">kanduri@uthscsa.edu<\/a>, <a href=\"nath@uthscsa.edu\">nath@uthscsa.edu<\/a><\/p>\n<hr>\n<h3 class=\"colorized-heading\">STUDY00001092: Nephrotic Syndrome Study Network. (Sponsor: University of Michigan)<\/h3>\n<p>The Nephrotic Syndrome Study Network (NEPTUNE) is a multi-year, multi-site collaborative study that conducts clinical and translational research on Focal Segmental Glomerulosclerosis (FSGS), Minimal Change Disease (MCD), and Membranous Nephropathy (MN) that present as Nephrotic Syndrome (NS).<\/p>\n<ul>\n<li>Age: adults more than 18 years of age<\/li>\n<li>Diagnosis: glomerular disease requiring kidney biopsy<\/li>\n<li>Location: Texas Diabetes Institute, UT Gateway Clinic, University Hospital<\/li>\n<\/ul>\n<p>Principal Investigator: Swetha R. Kanduri, MD<br \/>\nContact: 210 450 8333, <a href=\"kanduri@uthscsa.edu\">kanduri@uthscsa.edu<\/a> , <a href=\"nath@uthscsa.edu\">nath@uthscsa.edu<\/a><br \/>\n<a class=\"carat-double\" href=\"https:\/\/www.neptune-study.org\/\">Enroll in trial<\/a><\/p>\n<hr>\n<h3 class=\"colorized-heading\">ZENITH High Proteinuria: A Phase III, Randomised, Multicentre, Double-blind Study to Evaluate the Efficacy, Safety and Tolerability of Zibotentan\/Dapagliflozin FDC Compared to Dapagliflozin Alone in Participants with Chronic Kidney Disease and High Proteinuria (Sponsor: Astra-Zeneca)<\/h3>\n<p>This is a Phase III, randomised, multicentre, double-blinded study to evaluate efficacy, safety and tolerability of treatment with zibotentan\/dapagliflozin combination and dapagliflozin alone in chronic kidney disease patients with high proteinuria.<\/p>\n<ul>\n<li>Age: 18 Years to 95 Years<\/li>\n<li>Diagnosis: CKD, defined as eGFR \u2265 20 and &lt; 90 mL\/min\/1.73 m2 and UACR &gt; 700 mg\/g (&gt; 79 mg\/mmol) or UPCR &gt; 1000 mg\/g (&gt; 113 mg\/mmoL).<\/li>\n<li>Location: Texas Diabetes Institute<\/li>\n<\/ul>\n<p>Principal Investigator: Shweta Bansal, MD<br \/>\nContact: 210 450 9097, <a href=\"bansals3@uthscsa.edu\">bansals3@uthscsa.edu<\/a>, <a href=\"nath@uthscsa.edu\">nath@uthscsa.edu<\/a>, <a href=\"polancoj@uthscsa.edu\">polancoj@uthscsa.edu <\/a><br \/>\n<a class=\"carat-double\" href=\"https:\/\/clinicaltrials.gov\/study\/NCT06087835\">Enroll in trial<\/a><\/p>\n<hr>\n<h3 class=\"colorized-heading\">ZEUS: A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation (Sponsor: NovoNordisk)<\/h3>\n<p>This study evaluates if ziltivekimab reduces the risk of having cardiovascular events in people with cardiovascular disease, chronic kidney disease and inflammation.<\/p>\n<ul>\n<li>18 Years and older<\/li>\n<li>Estimated glomerular filtration rate (eGFR) between &gt;= 15 and below 60 mL\/min\/1.73 m^2<\/li>\n<li>Urinary albumin-to-creatinine ratio (UACR) &gt;= 200 milligrams per gram (mg\/g) and eGFR &gt;= 60 mL\/min\/1.73 m2<\/li>\n<li>hs-CRP greater than or equal to 2 milligram per liter (mg\/L)<\/li>\n<li>Evidence of atherosclerotic cardiovascular disease (ASCVD)<\/li>\n<li>Location: Texas Diabetes Institute<\/li>\n<\/ul>\n<p>Principal Investigator: Shweta Bansal, MD<br \/>\nContact: 210 450 9097, <a href=\"bansals3@uthscsa.edu\">bansals3@uthscsa.edu<\/a>, <a href=\"nath@uthscsa.edu\">nath@uthscsa.edu<\/a>, <a href=\"polancoj@uthscsa.edu\">polancoj@uthscsa.edu<\/a><br \/>\n<a class=\"carat-double\" href=\"https:\/\/clinicaltrials.gov\/study\/NCT05021835\">Enroll in trial<\/a><\/p>\n<hr>\n<h3 class=\"colorized-heading\">REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels. (Sponsor: NovoNordisk)<\/h3>\n<p>This study investigates the effects of CagriSema compared to placebo on cardiovascular events in people with cardiovascular disease.<\/p>\n<ul>\n<li>55 Years and older<\/li>\n<li>Established cardiovascular disease<\/li>\n<li>Diagnosed with type 2 diabetes mellitus (T2D)<\/li>\n<li>HbA1c 6.5%-10%<\/li>\n<li>Location: Texas Diabetes Institute<\/li>\n<\/ul>\n<p>Principal Investigator: Shweta Bansal, MD<br \/>\nContact: 210 450 9097, <a href=\"bansals3@uthscsa.edu\">bansals3@uthscsa.edu<\/a>, <a href=\"nath@uthscsa.edu\">nath@uthscsa.edu<\/a>, <a href=\"polancoj@uthscsa.edu\">polancoj@uthscsa.edu<\/a><br \/>\n<a class=\"carat-double\" href=\"https:\/\/clinicaltrials.gov\/study\/NCT05669755\">Enroll in trial<\/a><\/p>\n<hr>\n<h3 class=\"colorized-heading\">FIND-CKD: A Trial to Learn How Well Finerenone Works and How Safe it is in Adult Participants With Non-diabetic Chronic Kidney Disease (FIND-CKD) (Sponsor: Bayer)<\/h3>\n<p>This study evaluates if finerenone, a blocker of hormone aldosterone, helps to slow down the worsening of kidney function in participants with non-diabetic CKD compared to a placebo.<\/p>\n<ul>\n<li>18 Years and older<\/li>\n<li>Chronic kidney disease<\/li>\n<li>Urine albumin\/creatinine ratio (UACR) of \u2265 200 but \u2264 3500 mg\/g and estimated glomerular filtration rate (eGFR) \u2265 25 but &lt; 90 mL\/min\/1.73m^2<\/li>\n<li>K+ \u2264 4.8 mmol\/L at screening<\/li>\n<li>Location: Texas Diabetes Institute<\/li>\n<\/ul>\n<p>Principal Investigator: Shweta Bansal, MD<br \/>\nContact: 210 450 9097, <a href=\"bansals3@uthscsa.edu\">bansals3@uthscsa.edu<\/a>, <a href=\"nath@uthscsa.edu\">nath@uthscsa.edu<\/a>, <a href=\"polancoj@uthscsa.edu\">polancoj@uthscsa.edu<\/a><br \/>\n<a class=\"carat-double\" href=\"https:\/\/clinicaltrials.gov\/study\/NCT05047263\">Enroll in trial<\/a><\/p>\n<hr>\n<h3 class=\"colorized-heading\">BRISK: Bupropion for Fatigue in End-stage Kidney Disease Patients on Hemodialysis. (Sponsor: Investigator Initiated)<\/h3>\n<ul>\n<li>18 to 65 years<\/li>\n<li>On hemodialysis for at least 3 months<\/li>\n<li>Reports significant fatigue on dialysis days<\/li>\n<li>Location: Dialysis Medical Center<\/li>\n<\/ul>\n<p>Principal Investigator: Subrata Debnath, Ph.D.<br \/>\nContact: 210 450 8333, <a href=\"nath@uthscsa.edu\">nath@uthscsa.edu<\/a><br \/>\n<a class=\"carat-double\" href=\"https:\/\/clinicaltrials.gov\/study\/NCT06609343\">Enroll in trial<\/a><\/p>\n<hr>\n<h3 class=\"colorized-heading\">OASIS: Oral intradialytic amino acids supplementation to vitalize end-stage kidney disease patients on hemodialysis. (Sponsor: Investigator Initiated)<\/h3>\n<ul>\n<li>18 to 65 years<\/li>\n<li>On hemodialysis for at least 3 months<\/li>\n<li>Reports significant fatigue on dialysis days<\/li>\n<li>Location: Dialysis West<\/li>\n<\/ul>\n<p>Principal Investigator: Subrata Debnath, Ph.D.<br \/>\nContact: 210 450 8333, <a href=\"nath@uthscsa.edu\">nath@uthscsa.edu<\/a><br \/>\n<a class=\"carat-double\" href=\"https:\/\/clinicaltrials.gov\/study\/NCT05705414\">Enroll in trial<\/a><\/p>\n<hr>\n<h2><strong>Trial activation in progress:<\/strong><\/h2>\n<h3 class=\"colorized-heading\">ICAN: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ravulizumab in Adult Participants with Immunoglobulin A Nephropathy (IgAN) (Sponsor: Alexion Pharmaceuticals, Inc)<\/h3>\n<ul>\n<li>18 Years and older<\/li>\n<li>Documentation of IgAN diagnosis established on kidney biopsy<\/li>\n<li>eGFR \u2265 30 mL\/min\/1.73 m^2.<\/li>\n<li>UPCR \u2265 0.75 g\/g or UP \u22651 g\/day.<\/li>\n<li>Location: UT Gateway clinic<\/li>\n<\/ul>\n<p>Principal Investigator: Karthik Kovvuru, MD<br \/>\nContact: 210 450 8333, <a href=\"kovvuru@uthscsa.edu\">kovvuru@uthscsa.edu<\/a><br \/>\n<a class=\"carat-double\" href=\"https:\/\/clinicaltrials.gov\/study\/NCT06291376\">Enroll in trial<\/a><\/p>\n<hr>\n<h3 class=\"colorized-heading\">EASi-KIDENY: The Studies of Heart &amp; Kidney Protection With BI 690517 in Combination With Empagliflozin. (Sponsor: Boehringer Ingelheim)<\/h3>\n<ul>\n<li>18 Years and older<\/li>\n<li>eGFR \u226520 &lt;45 mL\/min\/1.73m\u00b2; or \u226545 &lt;90 mL\/min\/1.73m\u00b2 with urine albumin-to-creatinine ratio (uACR) \u2265200 mg\/g (or protein-to-creatinine ratio \u2265300 mg\/g).<\/li>\n<li>Not on Adosterone Synthase inhibitor (ASi) or Mineralocorticoid Receptor Antagonist (MRA)<\/li>\n<li>Location: Texas Diabetes Institute<\/li>\n<\/ul>\n<p>Principal Investigator: Shweta Bansal, MD<br \/>\nContact: 210 450 9097, <a href=\"bansals3@uthscsa.edu\">bansals3@uthscsa.edu<\/a>, <a href=\"nath@uthscsa.edu\">nath@uthscsa.edu<\/a>, <a href=\"polancoj@uthscsa.edu\">polancoj@uthscsa.edu<\/a><br \/>\n<a class=\"carat-double\" href=\"https:\/\/clinicaltrials.gov\/study\/NCT06531824?cond=(CORTICOSTERONE%20METHYLOXIDASE%20TYPE%20I%20DEFICIENCY)%20OR%20(CYP11B2)&amp;rank=2\">Enroll in trial<\/a><\/p>\n<hr>\n<h3 class=\"colorized-heading\">POSIBIL6_ESKD: Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (Sponsor: CSL Behring)<\/h3>\n<ul>\n<li>Male or female at least 18 years of age<\/li>\n<li>A diagnosis of ESKD undergoing maintenance dialysis for at least 12 weeks<\/li>\n<li>Serum hs-CRP \u2265 2.0 mg\/L<\/li>\n<li>A diagnosis of diabetes mellitus<\/li>\n<li>Location: Dialysis West<\/li>\n<\/ul>\n<p>Principal Investigator: Shweta Bansal, MD<br \/>\nContact: 210 450 9097, <a href=\"bansals3@uthscsa.edu\">bansals3@uthscsa.edu<\/a>, <a href=\"nath@uthscsa.edu\">nath@uthscsa.edu<\/a>, <a href=\"polancoj@uthscsa.edu\">polancoj@uthscsa.edu<\/a><br \/>\n<a class=\"carat-double\" href=\"https:\/\/clinicaltrials.gov\/study\/NCT05485961\">Enroll in trial<\/a><\/p>\n<hr>\n<p>[\/vc_column_text][\/vc_column][vc_column width=&#8221;1\/3&#8243;]<div class=\"panel outline\"><nav aria-label=\"Patient Care Services sub-navigation\" class=\"collapsible subnav\"><h2 class=\"close\">Patient Care Services<\/h2><ul id=\"menu-patient-care-services\" class=\"subnav leaf\" data-accordion-menu><li id=\"menu-item-2265\" class=\"menu-item menu-item-type-post_type menu-item-object-page menu-item-2265\"><a href=\"https:\/\/lsom.uthscsa.edu\/nephrology\/patient-care\/\">Overview<\/a><\/li>\n<li id=\"menu-item-2254\" class=\"menu-item menu-item-type-post_type menu-item-object-page menu-item-2254\"><a href=\"https:\/\/lsom.uthscsa.edu\/nephrology\/patient-care\/outpatient-dialysis-clinics-for-end-stage-renal-disease\/\">Outpatient Dialysis Clinics for End-Stage Renal Disease<\/a><\/li>\n<li id=\"menu-item-2255\" class=\"menu-item menu-item-type-post_type menu-item-object-page menu-item-2255\"><a href=\"https:\/\/lsom.uthscsa.edu\/nephrology\/patient-care\/outpatient-clinics-for-kidney-disease\/\">Outpatient Clinics for Kidney Disease<\/a><\/li>\n<li id=\"menu-item-2257\" class=\"menu-item menu-item-type-post_type menu-item-object-page menu-item-2257\"><a href=\"https:\/\/lsom.uthscsa.edu\/nephrology\/patient-care\/kidney-or-renal-transplant\/\">Kidney or Renal Transplant<\/a><\/li>\n<li id=\"menu-item-2800\" class=\"menu-item menu-item-type-custom menu-item-object-custom menu-item-2800\"><a href=\"https:\/\/pkdcure.org\/coe-search-results\/?search=78248\">Find ADPKD care<\/a><\/li>\n<li id=\"menu-item-2256\" class=\"menu-item menu-item-type-post_type menu-item-object-page menu-item-2256\"><a href=\"https:\/\/lsom.uthscsa.edu\/nephrology\/patient-care\/clinical-trials\/\">Clinical Trials<\/a><\/li>\n<li id=\"menu-item-2268\" class=\"menu-item menu-item-type-custom menu-item-object-custom menu-item-2268\"><a href=\"https:\/\/www.uthscsa.edu\/patient-care\/physicians\/clinics\/nephrology\">Practice Information<\/a><\/li>\n<\/ul><\/nav><\/div>[\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>[vc_row][vc_column width=&#8221;2\/3&#8243;][vc_column_text]Clinical trials are part of clinical research and are at the heart of all medical discoveries. Your voluntary participation in a clinical trial may lead to new and better treatment for kidney disease in near future. Nephrologists (kidney doctors) at UT Health San Antonio conduct clinical research trials. To learn more about how you [&hellip;]<\/p>\n","protected":false},"author":78,"featured_media":0,"parent":16,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page-templates\/child-page.php","meta":{"footnotes":""},"class_list":["post-699","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Clinical Trials - Nephrology<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/lsom.uthscsa.edu\/nephrology\/patient-care\/clinical-trials\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Clinical Trials - Nephrology\" \/>\n<meta property=\"og:description\" content=\"[vc_row][vc_column width=&#8221;2\/3&#8243;][vc_column_text]Clinical trials are part of clinical research and are at the heart of all medical discoveries. Your voluntary participation in a clinical trial may lead to new and better treatment for kidney disease in near future. Nephrologists (kidney doctors) at UT Health San Antonio conduct clinical research trials. To learn more about how you [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/lsom.uthscsa.edu\/nephrology\/patient-care\/clinical-trials\/\" \/>\n<meta property=\"og:site_name\" content=\"Nephrology\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-10T21:23:15+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/nephrology\\\/patient-care\\\/clinical-trials\\\/\",\"url\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/nephrology\\\/patient-care\\\/clinical-trials\\\/\",\"name\":\"Clinical Trials - Nephrology\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/nephrology\\\/#website\"},\"datePublished\":\"2018-07-25T16:56:44+00:00\",\"dateModified\":\"2025-09-10T21:23:15+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/nephrology\\\/patient-care\\\/clinical-trials\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/lsom.uthscsa.edu\\\/nephrology\\\/patient-care\\\/clinical-trials\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/nephrology\\\/patient-care\\\/clinical-trials\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/nephrology\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Patient Care\",\"item\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/nephrology\\\/patient-care\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Clinical Trials\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/nephrology\\\/#website\",\"url\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/nephrology\\\/\",\"name\":\"Nephrology\",\"description\":\"Division of Nephrology\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/nephrology\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Clinical Trials - Nephrology","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/lsom.uthscsa.edu\/nephrology\/patient-care\/clinical-trials\/","og_locale":"en_US","og_type":"article","og_title":"Clinical Trials - Nephrology","og_description":"[vc_row][vc_column width=&#8221;2\/3&#8243;][vc_column_text]Clinical trials are part of clinical research and are at the heart of all medical discoveries. Your voluntary participation in a clinical trial may lead to new and better treatment for kidney disease in near future. Nephrologists (kidney doctors) at UT Health San Antonio conduct clinical research trials. To learn more about how you [&hellip;]","og_url":"https:\/\/lsom.uthscsa.edu\/nephrology\/patient-care\/clinical-trials\/","og_site_name":"Nephrology","article_modified_time":"2025-09-10T21:23:15+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/lsom.uthscsa.edu\/nephrology\/patient-care\/clinical-trials\/","url":"https:\/\/lsom.uthscsa.edu\/nephrology\/patient-care\/clinical-trials\/","name":"Clinical Trials - Nephrology","isPartOf":{"@id":"https:\/\/lsom.uthscsa.edu\/nephrology\/#website"},"datePublished":"2018-07-25T16:56:44+00:00","dateModified":"2025-09-10T21:23:15+00:00","breadcrumb":{"@id":"https:\/\/lsom.uthscsa.edu\/nephrology\/patient-care\/clinical-trials\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/lsom.uthscsa.edu\/nephrology\/patient-care\/clinical-trials\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/lsom.uthscsa.edu\/nephrology\/patient-care\/clinical-trials\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/lsom.uthscsa.edu\/nephrology\/"},{"@type":"ListItem","position":2,"name":"Patient Care","item":"https:\/\/lsom.uthscsa.edu\/nephrology\/patient-care\/"},{"@type":"ListItem","position":3,"name":"Clinical Trials"}]},{"@type":"WebSite","@id":"https:\/\/lsom.uthscsa.edu\/nephrology\/#website","url":"https:\/\/lsom.uthscsa.edu\/nephrology\/","name":"Nephrology","description":"Division of Nephrology","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/lsom.uthscsa.edu\/nephrology\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/lsom.uthscsa.edu\/nephrology\/wp-json\/wp\/v2\/pages\/699","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lsom.uthscsa.edu\/nephrology\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/lsom.uthscsa.edu\/nephrology\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/lsom.uthscsa.edu\/nephrology\/wp-json\/wp\/v2\/users\/78"}],"replies":[{"embeddable":true,"href":"https:\/\/lsom.uthscsa.edu\/nephrology\/wp-json\/wp\/v2\/comments?post=699"}],"version-history":[{"count":0,"href":"https:\/\/lsom.uthscsa.edu\/nephrology\/wp-json\/wp\/v2\/pages\/699\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/lsom.uthscsa.edu\/nephrology\/wp-json\/wp\/v2\/pages\/16"}],"wp:attachment":[{"href":"https:\/\/lsom.uthscsa.edu\/nephrology\/wp-json\/wp\/v2\/media?parent=699"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}